Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (582)
- Volume 11, 2024 (58)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Archive: Volume 11, 2024
- default (58)
- The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC) (11)
- Advanced Radiation Therapy and Radiobiology for Hepatocellular Carcinoma (5)
- Combination of Immune Checkpoint Inhibitors and Locoregional Therapy of Hepatocellular Carcinoma: Hype or Hope (1)
- Insights and Innovations in Imaging for Hepatocellular Carcinoma: Advancing Diagnosis and Management (3)
A Modified Targetoid Feature Emphasizing Thin-Rim APHE to Improve the Diagnostic Performance of LI-RADS for Malignant Hepatic Tumors
Huang R, Zheng C, Xu G, Chen X, Shen J, Mao S
Journal of Hepatocellular Carcinoma 2024, 11:775-786
Published Date: 26 April 2024
Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study
Hu Z, Zhou H
Journal of Hepatocellular Carcinoma 2024, 11:767-774
Published Date: 24 April 2024
A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation
Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z
Journal of Hepatocellular Carcinoma 2024, 11:747-766
Published Date: 23 April 2024
Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y
Journal of Hepatocellular Carcinoma 2024, 11:737-746
Published Date: 18 April 2024
Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study
Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B
Journal of Hepatocellular Carcinoma 2024, 11:721-735
Published Date: 8 April 2024
Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors
Gonvers S, Martins-Filho SN, Hirayama A, Calderaro J, Phillips R, Uldry E, Demartines N, Melloul E, Park YN, Paradis V, Thung SN, Alves V, Sempoux C, Labgaa I
Journal of Hepatocellular Carcinoma 2024, 11:707-719
Published Date: 6 April 2024
Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z
Journal of Hepatocellular Carcinoma 2024, 11:693-705
Published Date: 4 April 2024
Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery
Shao G, Ma Y, Qu C, Gao R, Zhu C, Qu L, Liu K, Li N, Sun P, Cao J
Journal of Hepatocellular Carcinoma 2024, 11:679-691
Published Date: 3 April 2024
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis
Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, Wei W, Guo R
Journal of Hepatocellular Carcinoma 2024, 11:665-678
Published Date: 4 April 2024
High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization
Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D
Journal of Hepatocellular Carcinoma 2024, 11:651-663
Published Date: 27 March 2024
The State of Systematic Therapies in Clinic for Hepatobiliary Cancers
Chen W, Hu Z, Li G, Zhang L, Li T
Journal of Hepatocellular Carcinoma 2024, 11:629-649
Published Date: 27 March 2024
The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients
Ma X, Sun X, Xie F, Jian W, Wang Q, Xie Y, Li C, Zhang K
Journal of Hepatocellular Carcinoma 2024, 11:619-628
Published Date: 25 March 2024
Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions
Long X, Zeng H, Zhang Y, Lu Q, Cao Z, Shu H
Journal of Hepatocellular Carcinoma 2024, 11:607-618
Published Date: 23 March 2024
Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis
Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK
Journal of Hepatocellular Carcinoma 2024, 11:595-606
Published Date: 20 March 2024
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G
Journal of Hepatocellular Carcinoma 2024, 11:581-594
Published Date: 19 March 2024
Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro
Du YQ, Yuan B, Ye YX, Zhou FL, Liu H, Huang JJ, Wei YF
Journal of Hepatocellular Carcinoma 2024, 11:565-580
Published Date: 19 March 2024
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]
Yang H, Cong T, Luo Y, Yang C, Ren J, Li X
Journal of Hepatocellular Carcinoma 2024, 11:563-564
Published Date: 14 March 2024
LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma
Wei H, Wu X, Huang L, Long C, Lu Q, Huang Z, Huang Y, Li W, Pu J
Journal of Hepatocellular Carcinoma 2024, 11:543-562
Published Date: 11 March 2024
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
Zong S, Huang G, Pan B, Zhao S, Ling C, Cheng B
Journal of Hepatocellular Carcinoma 2024, 11:525-542
Published Date: 12 March 2024
Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy
Qiao W, Sheng S, Li J, Jin R, Hu C
Journal of Hepatocellular Carcinoma 2024, 11:509-523
Published Date: 7 March 2024
Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation
Zhang BL, Liu J, Diao G, Chang J, Xue J, Huang Z, Zhao H, Yu L, Cai J
Journal of Hepatocellular Carcinoma 2024, 11:489-508
Published Date: 6 March 2024
Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma
Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X
Journal of Hepatocellular Carcinoma 2024, 11:477-488
Published Date: 4 March 2024
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy
Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z
Journal of Hepatocellular Carcinoma 2024, 11:463-475
Published Date: 4 March 2024
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
Chamseddine S, LaPelusa M, Xiao L, Mohamed YI, Lee SS, Hu ZI, Hatia RI, Hassan M, Yao JC, Duda DG, Datar S, Amin HM, Kaseb AO
Journal of Hepatocellular Carcinoma 2024, 11:455-461
Published Date: 4 March 2024
Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma
Hall JT, Moon AM, Young M, Tan X, Darawsheh R, Danquah F, Tepper JE, Yanagihara TK
Journal of Hepatocellular Carcinoma 2024, 11:443-454
Published Date: 5 March 2024
Multiple Machine-Learning Fusion Model Based on Gd-EOB-DTPA-Enhanced MRI and Aminotransferase-to-Platelet Ratio and Gamma-Glutamyl Transferase-to-Platelet Ratio to Predict Microvascular Invasion in Solitary Hepatocellular Carcinoma: A Multicenter Study
Wang F, Yan CY, Qin Y, Wang ZM, Liu D, He Y, Yang M, Wen L, Zhang D
Journal of Hepatocellular Carcinoma 2024, 11:427-442
Published Date: 29 February 2024
Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers
Huang C, Xiao X, Tong L, Gao Z, Ji J, Zhou L, Li Y, Liu L, Feng H, Fang M, Gao C
Journal of Hepatocellular Carcinoma 2024, 11:411-425
Published Date: 27 February 2024
Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study
Cai H, Chen S, Wu Z, Wang F, Tang S, Chen L, Guo W
Journal of Hepatocellular Carcinoma 2024, 11:399-409
Published Date: 26 February 2024
A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization
Sun Z, Li X, Liang H, Shi Z, Ren H
Journal of Hepatocellular Carcinoma 2024, 11:385-397
Published Date: 26 February 2024
Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
Liang Y, Zhong D, Yang Q, Tang Y, Qin Y, Su Y, Huang X, Shang J
Journal of Hepatocellular Carcinoma 2024, 11:373-383
Published Date: 22 February 2024
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?
Himmelsbach V, Koch C, Trojan J, Finkelmeier F
Journal of Hepatocellular Carcinoma 2024, 11:363-372
Published Date: 19 February 2024
Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia
Alolyan A, Alshammari K, Arabi M, Alshehri A, Alsuhaibani H, Ibnshamsah F, Alsharm A, Mahrous M, Al Zanbagi A, Hassanain M, Bazarbashi S
Journal of Hepatocellular Carcinoma 2024, 11:349-362
Published Date: 16 February 2024
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Response to Letter]
Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y
Journal of Hepatocellular Carcinoma 2024, 11:347-348
Published Date: 14 February 2024
Lipid Metabolism as a Potential Target of Liver Cancer
Wu K, Lin F
Journal of Hepatocellular Carcinoma 2024, 11:327-346
Published Date: 14 February 2024
The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions
Luo QQ, Li QN, Cai D, Jiang S, Liu SS, Liu MS, Lv C, Wang JK, Zhang KH, Wang T
Journal of Hepatocellular Carcinoma 2024, 11:317-325
Published Date: 8 February 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J
Journal of Hepatocellular Carcinoma 2024, 11:305-316
Published Date: 8 February 2024
RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer
Pang JS, Bai XM, Wan WJ, Kang T, Wen R, Li LP, Yin HH, Lu CM, Wen DY, He Y, Yang H
Journal of Hepatocellular Carcinoma 2024, 11:285-304
Published Date: 5 February 2024
Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation
Qiao W, Li J, Wang Q, Jin R, Zhang H
Journal of Hepatocellular Carcinoma 2024, 11:271-284
Published Date: 3 February 2024
Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States
Bteich F, Desai K, Zhang C, Kaur A, Levy RA, Bioh L, Wang A, Sultana S, Kaubisch A, Kinkhabwala M, Bellemare S, Fidvi S, Kanmaniraja D, Berkenblit R, Moon JY, Adedimeji A, Tow CY, Saenger Y
Journal of Hepatocellular Carcinoma 2024, 11:257-269
Published Date: 3 February 2024
Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma
Qiu X, Dong L, Wang K, Zhong X, Xu H, Xu S, Guo H, Wei X, Chen W, Xu X
Journal of Hepatocellular Carcinoma 2024, 11:241-255
Published Date: 2 February 2024
Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma
Zhang C, Tao Y, Yang R, Wang Y, Yu Y, Zhou Y
Journal of Hepatocellular Carcinoma 2024, 11:229-240
Published Date: 26 January 2024
A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy
Yang H, Lu L, Guo W, Gong B, Wang X, Chen Y, Chen X
Journal of Hepatocellular Carcinoma 2024, 11:219-228
Published Date: 25 January 2024
Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors
Shen J, Wang X, Yang G, Li L, Fu J, Xu W, Zhang Q, Pan X
Journal of Hepatocellular Carcinoma 2024, 11:207-217
Published Date: 24 January 2024
A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study
Wang H, Chen JJ, Yin SY, Sheng X, Wang HX, Lau WY, Dong H, Cong WM
Journal of Hepatocellular Carcinoma 2024, 11:191-206
Published Date: 24 January 2024
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy
Yang H, Cong T, Luo Y, Yang C, Ren J, Li X
Journal of Hepatocellular Carcinoma 2024, 11:175-189
Published Date: 24 January 2024
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Letter]
Chen C, Cai J, Li L
Journal of Hepatocellular Carcinoma 2024, 11:173-174
Published Date: 23 January 2024
The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma
Mai Y, Meng L, Deng G, Qin Y
Journal of Hepatocellular Carcinoma 2024, 11:159-171
Published Date: 19 January 2024
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease
Miao T, Lou X, Dong S, Zhang X, Guan W, Zhang Y, Li L, Yuan X, Ma D, Nan Y
Journal of Hepatocellular Carcinoma 2024, 11:145-157
Published Date: 18 January 2024
Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma
Wang Z, Kong L, Zhang R, Yang X, Cao Z, Xu T, Zhang H, Dou Y
Journal of Hepatocellular Carcinoma 2024, 11:131-143
Published Date: 16 January 2024
Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma
Huang X, Wang M, Zhang D, Zhang C, Liu P
Journal of Hepatocellular Carcinoma 2024, 11:113-129
Published Date: 16 January 2024
The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels
Cong T, Yang C, Cao Q, Ren J, Luo Y, Yuan P, Zheng B, Liu Y, Yang H, Kang W, Ou A, Li X
Journal of Hepatocellular Carcinoma 2024, 11:95-111
Published Date: 17 January 2024
First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison
Mahn R, Glüer OA, Sadeghlar F, Möhring C, Zhou T, Anhalt T, Monin MB, Kania A, Glowka TR, Feldmann G, Brossart P, Kalff JC, Schmidt-Wolf IGH, Strassburg CP, Gonzalez-Carmona MA
Journal of Hepatocellular Carcinoma 2024, 11:81-94
Published Date: 13 January 2024
Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation
Qiao W, Fan Z, Wang Q, Jin R, Hu C
Journal of Hepatocellular Carcinoma 2024, 11:65-79
Published Date: 13 January 2024
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy
Han R, Gan L, Lang M, Li G, Chen L, Tian X, Zhu K, Sun L, Song T
Journal of Hepatocellular Carcinoma 2024, 11:51-64
Published Date: 12 January 2024
PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation
Ghelfi J, Macek Jilkova Z, Sengel C, Brusset B, Teyssier Y, Costentin C, Mercey-Ressejac M, Dumolard L, Manceau M, Mathieu E, Bricault I, Decaens T
Journal of Hepatocellular Carcinoma 2024, 11:39-50
Published Date: 9 January 2024
Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Deng L, Sun Y, Wang H, Liao C, Li D, Xu G, Yang X
Journal of Hepatocellular Carcinoma 2024, 11:29-38
Published Date: 9 January 2024
PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma
Yan J, Li KX, Yu L, Yuan HY, Zhao ZM, Lin J, Wang CS
Journal of Hepatocellular Carcinoma 2024, 11:15-27
Published Date: 6 January 2024
An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma
Yang H, Lei G, Deng Z, Sun F, Tian Y, Cheng J, Yu H, Li C, Bai C, Zhang S, An G, Yang P
Journal of Hepatocellular Carcinoma 2024, 11:1-13
Published Date: 9 January 2024